Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significant publications in diabetes pharmacotherapy and technology in 2020.
Clements JN, Franks R, Isaacs D, Malloy K, Meade LT, Reece SM, Reid DJ, Ward ED. Clements JN, et al. Among authors: isaacs d. Expert Rev Endocrinol Metab. 2023 Mar;18(2):131-142. doi: 10.1080/17446651.2023.2187779. Epub 2023 Mar 7. Expert Rev Endocrinol Metab. 2023. Retraction in: Expert Rev Endocrinol Metab. 2023 Mar;18(2):ii. doi: 10.1080/17446651.2023.2195265 PMID: 36882974 Retracted. Review.
Diabetes technology: A primer for clinicians.
Ambalavanan J, Isaacs D, Lansang MC. Ambalavanan J, et al. Among authors: isaacs d. Cleve Clin J Med. 2024 Jun 3;91(6):353-360. doi: 10.3949/ccjm.91a.23073. Cleve Clin J Med. 2024. PMID: 38830704 Free article. Review.
Association of SGLT-2 Inhibitors With Treatment Satisfaction and Diabetes-Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 Diabetes.
Ding Q, Spatz ES, Bena JF, Morrison SL, Levay M, Lin H, Grey M, Edwards NE, Isaacs D, West L, Combs P, Albert NM. Ding Q, et al. Among authors: isaacs d. J Am Heart Assoc. 2023 Sep 5;12(17):e029058. doi: 10.1161/JAHA.122.029058. Epub 2023 Sep 1. J Am Heart Assoc. 2023. PMID: 37655510 Free PMC article.
De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D).
Rodriguez P, Breslaw N, Xiao H, Bena J, Jenkins K, Isaacs D, Zhou K, Griebeler ML, Burguera B, Pantalone KM; TRANSITION‐T2D Investigators. Rodriguez P, et al. Among authors: isaacs d. Diabetes Obes Metab. 2024 Nov 12. doi: 10.1111/dom.16057. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39532398
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.
Simonson GD, Criego AB, Battelino T, Carlson AL, Choudhary P, Franc S, Gershenoff D, Grunberger G, Hirsch IB, Isaacs D, Johnson ML, Kerr D, Kruger DF, Mathieu C, Martens TW, Nimri R, Oser SM, Peters AL, Weinstock RS, Wright EE, Wysham CH, Bergenstal RM. Simonson GD, et al. Among authors: isaacs d. Diabetes Technol Ther. 2024 Nov;26(11):814-822. doi: 10.1089/dia.2024.0107. Epub 2024 Jun 10. Diabetes Technol Ther. 2024. PMID: 38758213
808 results